Article info

Original article
The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective

Authors

  1. Correspondence to Professor Martin R Cowie, Imperial College London, Dovehouse Street, London SW3 6LY, UK; m.cowie{at}imperial.ac.uk
View Full Text

Citation

Griffiths A, Paracha N, Davies A, et al
The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective

Publication history

  • Received July 12, 2013
  • Revised December 16, 2013
  • Accepted February 9, 2014
  • First published March 14, 2014.
Online issue publication 
June 09, 2014

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.